Second Generation Drug-Eluting Stent Implantation Followed by Six- Versus Twelve-Month Dual Antiplatelet Therapy - SECURITY


The optimal duration of dual antiplatelet therapy (DAPT) following drug-eluting stent (DES) percutaneous coronary intervention (PCI) remains unclear. The current trial sought to investigate the utility of a short duration of DAPT (6 months) versus 12 months following PCI with a second-generation DES.